Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology

J Cancer Res Clin Oncol. 2021 Jan;147(1):295-301. doi: 10.1007/s00432-020-03440-2. Epub 2020 Nov 9.

Abstract

Purpose: Peripheral blood T lymphocytosis (PBTL) is a rare, yet poorly understood manifestations of thymoma, which is postulated to be linked with autoimmune/paraneoplastic manifestations such as myasthenia gravis (MG), pure red cell aplasia (PRCA), etc.; more commonly encountered in this neoplasm.

Method: We aim to describe the flowcytometric immunophenotypic data of PBTL in a 43-year-old male; 6 months after successful completion of chemoradiotherapy (CT/RT) for a large, invasive, and metastatic type B1 thymoma; and present a comprehensive review of all such cases reported over last 42 years (N = 21) (1977-2019).

Result: A larger size of the tumors (≥ 10 cm), presence of local invasion and/or distant metastasis, and type B (cortical or lymphocyte rich) histology were more likely to be associated with PBTL. Tumors associated with MG/PRCA (N = 9/21) tend to have lower PBTL compared to those without such manifestations; and PBTL subsided following thymectomy with or without CT/RT. Immunophenotypic analysis of PB revealed a CD8 + > CD4 + mature (naïve) polyclonal T cells resembling late cortical thymocytes.

Conclusion: Thymic intratumoral microenvironment might influence occurrence PBTL that may have a pathophysiologic link to development of autoimmune manifestations. Immunophenotypic characteristics of peripheral blood lymphoid cells should be the clue for accurate characterization and to avoid a misdiagnosis of a lymphoproliferative neoplasm.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Chemoradiotherapy / methods
  • Humans
  • Lymphocytosis / complications
  • Lymphocytosis / immunology
  • Lymphocytosis / pathology*
  • Lymphocytosis / therapy
  • Male
  • Prognosis
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology*
  • Thymoma / complications
  • Thymoma / immunology
  • Thymoma / pathology*
  • Thymoma / therapy
  • Thymus Neoplasms / complications
  • Thymus Neoplasms / immunology
  • Thymus Neoplasms / pathology*
  • Thymus Neoplasms / therapy